MedPath
NMPA Approval

Fudosteine Oral Solution

国药准字H20244662

August 20, 2024

Drug Information

福多司坦口服溶液

口服溶液剂

100ml:8g

化学药品

August 20, 2024

Company Information

Applicant Company

北京市昌平区科技园振兴路2号院4号楼3层4301

Manufacturing Company

珠海市金湾区三灶镇定湾四路128号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

福多司坦口服溶液 - NMPA 批准文号 | MedPath